Skip to content
CancerIndex

Publication

PARP7 inhibitors enhance the immunogenic effects of radiation in pancreatic cancer cells.

Niccolò Bragato, Ana Beatriz Dias, Anna Ohradanova-Repic, Alma Dupanovic, Filip Horvat, Patrick Fischer, Lisa-Marie Appel, Lena Walch, Ava Kleinwächter, Anna Röhrer, Sylvia Kerschbaum-Gruber, Sandra Barna, Piero Fossati, Dietmar Georg, Joachim Widder, Klaus Podar, Michael Cohen, Dea Slade

Molecular therapy. OncologySep 17, 2026PMID 42383254doi:10.1016/j.omton.2026.201258 PMC13316578Journal ArticlepubmedProvenance
Source
PubMed
Retrieved
Sep 19, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-PUBMED-20260919-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

Pancreatic ductal adenocarcinoma (PDAC) is the most frequent type of pancreatic cancer with a poor prognosis and resistance to conventional radio- and chemotherapy. Radiation can induce pro-inflammatory signaling by activating the type 1 interferon (IFN-I) response, which can be enhanced by…

Read on PubMed

Linked entities

Linked entities (1)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Candidate 1

Curated evidence

Evidence citing this paper (0)

Data not yet available

No curated evidence item cites this publication.